Your weekly roundup of the latest news from Drug Topics®.
The decision comes following reports of 16,000 cases across 75 countries and territories around the world.
Research examines whether a step-approach with treatment for macular edema produces positive results.
Fentanyl, COVID-19 pandemic likely factors in 30% increase from previous year.
Novo Nordisk’s Saxenda (liraglutide) and Wegovy (semaglutide) are leading the way for a new crop of drugs that reduce appetite, but the cost-effectiveness is in question with many payers saying no to coverage.
Research indicates that the risk of certain conditions becomes significantly increased following a bout of COVID-19.